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T Helikar1, B Kowal1, and JA Rogers1
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Abstract
Diseases are often a result of multiple malfunctions in complex, nonlinear biological/biochemical 
networks. As such, these processes are far more complicated to understand because they tend to 
give rise to functions that are emergent in nature, i.e., higher-level (mal)functions that are more 
than the sum of their parts. Systems biology provides a new approach to understanding biological 
systems and diseases from a holistic perspective.
DYNAMICAL, WHOLE-CELL SYSTEMS BIOLOGY
A system of intracellular biochemical networks has been shown to have emergent functions 
such as nontrivial cellular decision making.1 A function such as this is not detectable by 
isolated observation of individual network elements; there is no single protein or gene, 
biochemical reaction, area, or substructure that is responsible for or correlated with the 
ultimate function or malfunction (i.e., disease) of the system. Therefore, understanding how 
diseases occur in these systems and coming up with a reasonable therapy require an 
integrated, systems analysis strategy. A key component of the systems approach lies in 
understanding not only the topology of the various networks but also the associated 
dynamics as the system evolves in time. This “dynamical” systems biology has the potential 
to shed new light on the dynamics of healthy cells and also to open doors to the development 
of more efficient/effective drug therapies.
To exploit the full potential of systems biology, significantly larger and eventually whole-
cell models will be needed. Recently, the first complete whole-cell model of Mycoplasma 
genitalium was created.2 This model incorporates all molecular constituents and their 
interactions and demonstrates how comprehensive whole-cell models can be used to further 
biomedical research via computer simulations and predictions of previously unobserved 
biological phenomena. This model was constructed by a single group of researchers; 
however, modeling the substantially larger and more complex human cells will likely require 
a large-scale, collaborative approach.
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A CROWD-SOURCING PLATFORM FOR SYSTEMS BIOLOGY
The dual problem of understanding emergent cellular function and rational drug discovery is 
a perfect candidate for the research application of the modern phenomenon of “crowd-
sourcing.” Scientific crowd-sourcing (e.g., EyeWire, http://www.eyewire.org; Galaxy Zoo, 
http://www.galaxyzoo.org; or the Polymath Project, http://www.polymathprojects.org) is a 
distributed problem-solving and production model in which the understanding of large-scale 
systems is created via a community of scientists contributing their detailed understanding of 
local areas of the system to create the large-scale system. Thus, knowledge of the individual 
system constituents is integrated into a global system that then has the potential to display 
emergent properties (including disease states as system malfunction) and that can be used to 
discover new drug targets. With such a system the promise of the systems biology approach 
can become a reality. It is with this idea in mind that we have developed the online 
community modeling system called the Cell Collective.3
Dynamical modeling frameworks range from differential equations, able to capture high 
levels of detail, to more coarse-grained approaches such as Boolean networks in which 
species are described digitally as either active or inactive. The rich information of kinetics 
contained in differential equations comes with the price of limited scalability and 
dependency on many difficult-to-obtain biological (kinetic) parameters. On the other hand, 
Boolean networks are discrete and qualitative (based on the logic of individual interactions), 
free of kinetic parameters, and relatively easy to construct, making them more suitable for 
large-scale system modeling. One of the drawbacks of traditional Boolean networks is that 
they are deterministic whereas biological systems are stochastic. The Cell Collective 
combines the easy-to-construct and parameter-free nature of qualitative modeling methods 
with the continuous data input/output and stochastic features of more detailed modeling 
approaches.
The software is designed to allow modeling of complex biological networks based on 
understanding of the logic of the interactions of the individual components. For instance, 
Akt, an important regulator of apoptosis, can be activated via phosphorylation by 
phosphoinositide-dependent protein kinase-1 (PDK1) or integrin-linked kinase (ILK). This 
activation step also requires the recruitment of Akt to the plasma membrane via 
phosphatidylinositol 4,5 bisphosphate (PIP2) or phosphatidylinositol 3,4,5-trisphosphate 
(PIP3). This regulatory mechanism of Akt can be easily and manually abstracted into a logic 
expression as (PDK1 OR ILK) AND (PIP2 OR PIP3). However, as models become more 
complex, larger, and interconnected, the number of regulatory components of a single 
species and hence the representing logic expression can become complex. For example, Rac, 
a regulator of cell motility, was included in our recent large-scale models in which its 
regulatory mechanism is governed by 16 interacting partners, resulting in a logic expression 
that is cumbersome, errorprone, and inefficient to create manually:
(RasGRF AND ¬(RhoGDI AND ¬PAK) AND ¬(p190RhoGAP AND Rac) AND 
¬(RalBP1 AND Rac) AND ECM AND Integrins) OR (Tiam AND ¬(RhoGDI 
AND ¬PAK) AND ¬(p190RhoGAP AND Rac) AND ¬(RalBP1 AND Rac) AND 
(ECM AND Integrins)) OR (PixCool AND ¬(RhoGDI AND ¬PAK) AND ((PAK 
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AND Gβγ AND ((¬Cdc42 AND ¬Rac) AND (Integrins AND ECM))) OR (¬Gβγ 
AND (Cdc42 AND (Integrins AND ECM) AND ¬Rac)) OR (¬PAK AND 
(¬RhoGDI AND (¬DOCK180 AND ¬(RhoGDI AND ¬PAK) AND 
¬(p190RhoGAP AND Rac) AND ¬(RalBP1 AND Rac) AND ¬RasGRF AND 
¬(RhoGDI AND ¬PAK) AND ¬(p190RhoGAP AND Rac) AND ¬(RalBP1 AND 
Rac) AND ¬Tiam AND ¬(RhoGDI AND ¬PAK) AND ¬(p190RhoGAP AND Rac) 
AND ¬(RalBP1 AND Rac)) AND (Integrins AND ECM) AND Cdc42 AND 
¬Rac)))) OR (DOCK180 AND ¬(RhoGDI AND ¬PAK) AND ¬(p190RhoGAP 
AND Rac) AND ¬(RalBP1 AND Rac) AND (ECM AND Integrins)).
Using the Cell Collective’s nontechnical, plain-English, and logic-based user interface, the 
creation of large-scale dynamical computational models eliminates the need to enter 
complex mathematics or computer code, making it a particularly useful tool for mainstream 
laboratory scientists (a brief tutorial on how to construct a simple model is available on the 
Cell Collective website; http://www.thecellcollective.org). The Web-based nature of the 
software provides a unique environment to support a crowd-sourcing approach to the 
construction, simulation, and analysis of complex computational models of biological 
systems (Figure 1). New laboratory results and/or results generated/predicted with the 
models (and subsequently verified experimentally) can be presented to the community as a 
candidate for incorporation into models published in the platform. Multiple rounds of 
modification in this manner result in continuous improvement and growth of these models, 
with the goal of reaching the scale of whole cells (Figure 1). Note that in order to account 
for interactions that may differ across different cell types, users can create new or “fork” 
existing models to build models representing different cell types. Although the platform has 
been designed as a collaborative modeling approach, users can also create private models or 
share their models with a defined group of collaborators.
DRUG TARGET IDENTIFICATION VIA COMPUTER SIMULATIONS
Because models created in the Cell Collective are dynamical (with a time dimension), one 
can ask questions critical to drug therapy design, including “what parts of the system are 
most/least sensitive to perturbation?” and “what parts of the system are most/least influential 
on the rest of the system when perturbed?” The real-time, interactive simulation features 
enables scientists to test many what-if scenarios while instantly observing the effects of 
changing environmental, pathogenic, and/or drug-induced conditions (Figure 2a).
Since its release, hundreds of models have been created in the Cell Collective, and a number 
of these models are now available to the scientific community for additional studies and 
contributions. For example, simulations of a new model of the molecular dynamics in 
influenza A replication reproduced a number of dynamical properties of the viral replication 
cycle under normal conditions as well as during treatment with various inhibitors.4 The 
model was also simulated to compare the effectiveness of the antiviral drugs amantadine/
rimantadine and zanamivir/oseltamivir with a drug targeting the polymerase acidic protein-
polymerase basic 1 protein (PA:PB1) complex (Figure 2b). In another study, to better 
understand the role of ErbB signaling in the progression of breast cancer, a multiscale model 
of signal transduction in human mammary epithelial cells consisting of 240+ molecular 
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species and 1,100+ biochemical interactions was developed and used to predict inducing 
effects of Src overexpression on the internalization of epidermal growth factor receptor; this 
prediction was subsequently verified experimentally (Figure 2c). (See Supplementary Data 
online for additional references and application use cases.)
Because the computational framework behind the Cell Collective is based on a widely used 
modeling and simulation schema, the platform is compatible with a plethora of previously 
published modeling efforts (some of which are now available in the Cell Collective and are 
summarized and referenced in the Supplementary Data online), including studies on 
migration of keratinocytes, Fanconi anemia/breast cancer pathway, yeast cell cycle, T-cell 
differentiation (Figure 2a), and drug-target identification in the G1/S cell-cycle transition, as 
well as a 300+ node model of signal transduction in macrophages.
SUMMARY
Rather than applying relatively simplistic strategies for direct intervention at intuitively 
obvious sites, the ability to interrogate biological networks in a systemic context in order to 
search for nonintuitive approaches cannot be underestimated. Current and future discoveries 
in quantitative analysis will be difficult or even impossible to apply in the absence of large-
scale, accurate models of biochemical/biological systems. We hope that as models in the 
Cell Collective become more comprehensive, they will provide new opportunities not only 
to identify and rank individual potential drug targets but also to explore the possibilities of 
drug repurposing and combinatorial therapies.
Rational drug design/discovery is a major problem that has yet to succumb to the power of 
modern laboratory science. It is likely that more tools will be required to attack this problem, 
including new ones such as systems and computational approaches. The merging of the 
laboratory and quantitative analysis has the potential for exciting synergies, and the Cell 
Collective is designed as a platform on which these synergies can become a reality.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Overview of the flow of knowledge about biological processes and the role of the Cell 
Collective in integrating and understanding this knowledge in the context of the biological 
processes as a whole. (1) Laboratory scientists with expert understanding of various parts of 
the cell or cell types collectively integrate their local knowledge into the platform. (2) Using 
the Bio-Logic Builder (ref. 5), this local knowledge is integrated into central models using 
qualitative information (and without the need to enter mathematical expressions or computer 
code). (3) Dynamical models created in the Cell Collective can be simulated and 
interrogated to pretest existing hypotheses as well as generate new ones, including the 
predictions and ranking of potential drug targets and their effects. Adapted from ref. 3.
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Figure 2. 
Examples of the Cell Collective applications to large-scale models of biological systems. (a) 
Real-time simulation of a model of a biochemical network governing CD4+ T-cell 
differentiation. The model was simulated to study the reprogrammability of T-regulatory 
cells to T-helper 1 (Th1) cells on stimulation of the biochemical network with interferon-γ 
(IFNG) and interleukin 12–Th1 cell–inducing stimuli. This model is currently being used to 
better understand the plasticity and reprogrammability of T cells (data not shown). (b) 
Simulations of a large-scale dynamical model of the influenza A replication cycle and 
comparison of the effects of existing drugs with a proposed drug target, the PB1:PA 
interface, on the generation of progeny virions suggest that drugging the proposed target 
would be more efficient. (c) Predicted increase of epidermal growth factor receptor (EGFR) 
internalization induced by constitutive activation of the Src nonreceptor protein kinase. The 
y-axis in a–c and the x-axis in b correspond to the activity level of the noted model 
components; note that this measure does not correspond to biochemical concentrations but is 
rather a semiquantitative way to capture the effects of varying biological conditions. The x-
axis in a is an arbitrary time scale and does not correspond to real time. CCP, clathrin-coated 
pits; CCV, clathrin-coated vesicles; EGF, epidermal growth factor; FOXP3, forkhead box P3; 
MVB, multivesicular bodies; NA, neuraminidase; PB1:PA, polymerase basic 1 protein 
polymerase acidic protein complex; PM, plasma membrane; TBET, T-box expressed in T 
cells; WT, wild type.
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Example Applications and Models Available in the Cell Collective  
 
Application Reference 
Signal transduction in generic (fibroblast) cells. 
This model includes the Epidermal Growth Factor 
Receptor (EGFR), G-protein Coupled Receptor 
(GPCR), integrin, and stress pathways. 
[1] 
Budding yeast cell cycle [2] 
T-Cell differentiation (model currently 
unpublished, but based on a previously published 
model) 
[3] 
Molecular machinery of the influenza replication 
cycle 
[4] 
Multi-scale model of biochemical signal 
transduction in human epithelial cells 
[5] 
Keratinocyte migration [6] 
ErbB-regulated G1/S cell cycle transition [7] 
Fanconi Anemia/Breast Cancer pathway [8] 
Biochemical signal transduction in macrophage 
cells 
[9] 
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